Position
Optas, LLC in 10x Genomics, Inc.
Back to the book · All holders of TXG
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $110.1K$16.31 → $21.23
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 22.4K | $365.1K | — | — | — | 0.1% |
| Q1 2026 | 24.2K | $514.1K | $21.23 | $110.1K | $38.9K | 0.1% |